{"filing":{"accession_number":"0001193125-26-342384","cik":"0001861795","ticker":"DH","company_name":"Definitive Healthcare Corp.","form":"8-K","filing_date":"2026-08-10","report_date":"2026-08-10","primary_document":"dh-20260810.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1861795/000119312526342384/dh-20260810.htm"},"events":[{"id":26568,"run_id":24150,"accession_number":"0001193125-26-342384","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"This is a clear earnings release disclosing Definitive Healthcare's Q2 2026 financial results for the quarter ended June 30, 2026. The press release, furnished as Exhibit 99.1, presents key financial metrics including revenue ($55.2M), net loss, adjusted net income, adjusted EBITDA, and cash flow, along with forward guidance for Q3 and full-year 2026. The Item 2.02 disclosure and attached press release are the hallmark of an earnings announcement, which is material to investors assessing the company's operational and financial performance.","company_name":"Definitive Healthcare Corp.","ticker":"DH","filing_date":"2026-08-10","form":"8-K","submitted_at":null,"items":[{"id":27735,"accession_number":"0001193125-26-342384","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Definitive Healthcare's Q2 2026 financial results for the quarter ended June 30, 2026. The press release, furnished as Exhibit 99.1, presents key financial metrics including revenue ($55.2M), net loss, adjusted net income, adjusted EBITDA, and cash flow, along with forward guidance for Q3 and full-year 2026. The Item 2.02 disclosure and attached press release are the hallmark of an earnings announcement, which is material to investors assessing the company's operational and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T20:17:42.298313+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27735,"accession_number":"0001193125-26-342384","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Definitive Healthcare's Q2 2026 financial results for the quarter ended June 30, 2026. The press release, furnished as Exhibit 99.1, presents key financial metrics including revenue ($55.2M), net loss, adjusted net income, adjusted EBITDA, and cash flow, along with forward guidance for Q3 and full-year 2026. The Item 2.02 disclosure and attached press release are the hallmark of an earnings announcement, which is material to investors assessing the company's operational and financial performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T20:17:42.298313+00:00","company_name":"Definitive Healthcare Corp.","ticker":"DH","filing_date":"2026-08-10"}]}